Antimicrobial Agents and Chemotherapy · 2018 · 30 citations · 8 references
Life SciencesMicrobiologyPharmacologyAntimicrobial PharmacologyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial PharmacodynamicsBeta-lactam ResistanceAminoglycoside AntibioticsAminoglycoside Resistance MechanismsBactericidal AgentsComparatorsEscherichia ColiKlebsiella Pneumoniae ResistanceMinimum Bactericidal ConcentrationMulti-drug Resistance
The next-generation aminoglycoside plazomicin, in development for infections due to multidrug-resistant (MDR) Enterobacteriaceae , was evaluated alongside comparators for bactericidal activity in minimum bactericidal concentration (MBC) and time-kill (TK) assays against MDR Enterobacteriaceae isolates with characterized aminoglycoside and β-lactam resistance mechanisms. Overall, plazomicin and colistin were the most potent, with plazomicin demonstrating an MBC 50/90 of 0.5/4 μg/ml and sustained 3-log 10 kill against MDR Escherichia coli , Klebsiella pneumoniae , and Enterobacter spp.
8
Neil Woodford, Alessandra Carattoli, E. Karisik et al. · Antimicrobial Agents and Chemotherapy · 2009 · 286 citations · Full text
Andrea Endimiani, Andrea M. Hujer, Federico Pérez et al. · Journal of Antimicrobial Chemotherapy · 2009 · 214 citations · Full text
Yoichi Hirakata, Junichi Matsuda, Yoshitsugu Miyazaki et al. · Diagnostic Microbiology and Infectious Disease · 2005 · 155 citations